Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Intro highlights steps to build credit with a secured card while avoiding debt, emphasizing payment discipline and utilization management.
22,663 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
As the AI era expands, investors are eyeing a broader landscape beyond Nvidia. This article explores a rising AI infr...
Analysts argue the Micron rally isn’t over: AI memory demand and persistent supply tightness could propel shares high...
Rivian is under renewed investor scrutiny as the R2 launch tests demand and governance structure limits shareholder i...
Across major firms, AI agents now outnumber human staff in many back offices and customer channels. Leaders outline g...
A wave of selective rallies in WLD, XLM, and JTO underscores a fragile altcoin bounce. Analysts say hype is waning, w...
Oracle just posted its strongest quarter ever with massive cloud backlog, yet investors face a capital-heavy path ahe...
Markets show cautious gains as leaders shift from a tech-first mindset to human-centered growth rooted in local commu...
U.S. Q1 GDP was revised higher to a 2.1% annualized pace, topping prior estimates. The gain sparks relief in markets ...
Binance warns it may fail to win MiCA authorization by July 1, risking a European access cut. Traders face a scramble...
BitGo trims nearly 15% of its staff to sharpen focus on AI-powered infrastructure, stablecoins, and settlement servic...
As Medicare IRMAA surcharges loom, retirees face higher taxes on RMDs and reduced spendable cash. This report explain...